Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Johann W, Schmier"'
Autor:
Katharina Lisenko, Mathias Witzens-Harig, Hartmut Goldschmidt, Patrick Wuchter, Johann W. Schmier, Thomas Bruckner, Jens Hillengass, Gerlinde Egerer, Anthony D. Ho, Sandra Sauer, Sofia Shah
Publikováno v:
BMC Cancer
Background: High-dose (HD) chemotherapy with melphalan and autologous blood stem cell transplantation (ABSCT) for treatment of symptomatic multiple myeloma (MM) on an outpatient basis has been well established in the USA and Canada, whereas in German
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::abaa7ed6b9e60225e0075a4200dc9c25
http://archiv.ub.uni-heidelberg.de/volltextserver/22698/
http://archiv.ub.uni-heidelberg.de/volltextserver/22698/
Publikováno v:
Cancer. 123(16)
When bad news about a cancer diagnosis is being delivered, patient-centered communication (PCC) has been considered important for patients' adjustment and well-being. However, few studies have explored how interpersonal skills might help cancer patie
Autor:
Anthony D. Ho, Alwin Kraemer, Axel Benner, Mathias Witzens-Harig, Kai Neben, Manfred Hensel, Johann W. Schmier, Christian Kuhn, Ingo G.H. Schmidt-Wolf, Peter Dreger
Publikováno v:
Blood. 110:4472-4472
Clinical and pharmacokinetic data suggest that the effect of rituximab could be improved by prolonged exposure to the drug. To test for this hypothesis we performed a prospective randomized trial of rituximab maintenance therapy in patients with CD20
Autor:
Anthony D. Ho, Alwin Krämer, Ingo Schmidt-Wolf, Christian Kuhn, Peter Dreger, Axel Benner, Kai Neben, Johann W. Schmier, Manfred Hensel, Mathias Witzens-Harig
Publikováno v:
Blood. 108:4704-4704
Clinical and pharmacokinetic data suggest that the effect of rituximab could be improved by prolonged exposure to the drug. To test for this hypothesis we performed a prospective randomized trial of rituximab maintenance therapy in patients with CD20
Autor:
Alwin Kraemer, Axel Benner, Mathias Witzens-Harig, Kai Neben, Peter Dreger, Johann W. Schmier, Manfred Hensel, Anthony D. Ho
Publikováno v:
Blood. 106:2454-2454
Clinical and pharmacokinetic data suggest that the effect of rituximab could be improved by prolonged exposure to the drug. To test for this hypothesis we performed a prospective randomized trial of rituximab maintenance therapy in patients with CD20